Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P210032/S019

GORE TAG Thoracic Branch Endoprosthesis (TBE Device)

W. L. Gore & Associates, Inc. · Decision date Aug 21, 2025

FDA DECISIONP210032/S019

What did the FDA approve?

FDA records P210032/S019 as a supplement to PMA P210032, with the supplement type “Normal 180 Day Track No User Fee”. The recorded decision is approval, dated Aug 21, 2025.

FDA approval order statement

approval of the protocol for the post-approval study (PAS) referenced above. The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P210032/S015.
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track No User Fee
Clinical specialty
Cardiovascular
Decision date
Aug 21, 2025
FDA change category
Postapproval Study Protocol

FDA source record

Regulatory record facts

Identifier
P210032/S019
Regulatory pathway
PMA supplement
Product code
MIH
Decision code
APPR
Decision date
Aug 21, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT.

Product code
MIH
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P210032/S019 received

    Application receipt date recorded by FDA.

  2. P210032/S019 · FDA decision

    Normal 180 Day Track No User Fee

  3. P210032/S022 · Related supplement

    TAG Thoracic Branch Endoprosthesis (P210032)

  4. P210032/S023 · Related supplement

    GORE TAG Thoracic Branch Endoprosthesis

  5. P210032/S024 · Related supplement

    GORE TAG Thoracic Branch Endoprosthesis

  6. P210032/S025 · Related supplement

    GORE TAG Conformable Thoracic Stent Graft with ACTIVE CONTROL System

  7. P210032/S026 · Related supplement

    GORE TAG Thoracic Branch Endoprosthesis Zone 0/1

Timeline entries are records held by MedtechLedger for P210032. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P210032

Explore the linked device profile

Other records with product code MIH

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

W. L. Gore & Associates, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
3450 W. Kiltie Ln., Flagstaff, AZ, 86005

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records